Search Results

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2...

by Strickler, John H, Cercek, Andrea, Siena, Salvatore, André, Thierry, Ng, Kimmie, Van Cutsem, Eric, Wu, Christina, Paulson, Andrew S, Hubbard, Joleen M, Coveler, Andrew L, Fountzilas, Christos, Kardosh, Adel, Kasi, Pashtoon M, Lenz, Heinz-Josef, Ciombor, Kristen K, Elez, Elena, Bajor, David L, Cremolini, Chiara, Sanchez, Federico, Stecher, Michael, Feng, Wentao, Bekaii-Saab, Tanios S
Published in The Lancet Oncology (2023)